The generalized myasthenia gravis treatment pipeline features several promising late-stage candidates, including IMVT-1402 (Immunovant/Roivant Sciences), Descartes-08 (Cartesian Therapeutics), Remibrutinib (Novartis),…
Rising adoption of connected fitness platforms, 5G-enabled streaming, and cost-effective home workouts drive a projected 28.6% CAGR through 2035. Austin,…
Precedence Research introduces its AI-powered market intelligence service, offering real-time analytics, predictive forecasting, and competitive insights across 13+ industries. Ottawa,…
Bengaluru, India, April 15, 2026 (GLOBE NEWSWIRE) — Zoomcar Holdings, Inc. (OTCQB: ZCAR) (the “Company”), the leading peer-to-peer self-drive car-sharing…
Rising Hospital Sustainability Mandates and Cost-Containment Strategies Fuel a Projected 15.35% CAGR in Global Reprocessing Sector. Austin, United States, April…